Haslam Family's $12.5 Million Investment in CLL Research: A Beacon of Hope for Rare Disease Treatment
Dee Haslam's diagnosis of chronic lymphocytic leukemia in 2021 led her and her husband Jimmy, owners of the Cleveland Browns and managing partners of Haslam Sports Group, to make a significant investment of $12.5 million in blood cancer research. This generous gift is aimed at supporting the University Hospitals Seidman Cancer Center and the Oxford-Harrington Rare Disease Centre, with the goal of finding a cure for this common form of leukemia in adults.
Chronic lymphocytic leukemia, while manageable for many patients with modern therapies, still lacks a cure. As a rare disease, it falls into the category of conditions that have limited or no approved treatments. The Oxford-Harrington Rare Disease Centre, in collaboration with the Harrington Discovery Institute at University Hospitals, focuses on bridging this treatment gap by funding researchers dedicated to developing new medicines for patients in need.
The Haslams' donation is divided into two parts: $10 million will support the Oxford-Harrington Rare Disease Centre in accelerating drug development for CLL and related blood cancers, aiming to move new therapeutics into clinical trials with the ultimate goal of finding a cure. The remaining $2.5 million will benefit UH Seidman Cancer Center by establishing an endowed chair in CLL research and an innovation fund to drive advancements in patient care.
This commitment to CLL research is not the first for the Haslams, as they previously donated $2 million to Pelotonia in 2024 to fund CLL research at The Ohio State University Comprehensive Cancer Center. Additionally, their $20 million commitment in 2023 established the UH Haslam Sports Innovation Center, focusing on enhancing athletic performance and reducing injury risk. Dee Haslam's involvement on the University Hospitals Board of Directors further underscores their dedication to healthcare advancements.
The Haslams' latest contribution extends their philanthropic legacy into a deeply personal realm, with the potential to impact patients well beyond Cleveland. With less than five percent of rare diseases having approved treatments, the Haslams are optimistic about making a difference in this area. The personal connection to CLL in Cleveland is highlighted by the story of Jim Donovan, a WKYC anchor and voice of the Cleveland Browns, who bravely battled the disease for 25 years before passing away in 2024. His resilience and impact on the community serve as a reminder of the importance of ongoing research and support for those affected by rare diseases.